Immunohistochemical and Reverse Transcription-Polymerase Chain Reaction Expression Analysis of Tyrosinase and Microphthalmia-Associated Transcription Factor in Angiomyolipomas-Reference-Cited by-同舟云学术

Immunohistochemical and Reverse Transcription-Polymerase Chain Reaction Expression Analysis of Tyrosinase and Microphthalmia-Associated Transcription Factor in Angiomyolipomas

Published:2001-03 Issue:1 Volume:9 Page:29-34
ISSN:1062-3345
Container-title:Applied Immunohistochemistry & Molecular Morphology
language:en
Short-container-title:Applied Immunohistochemistry & Molecular Morphology

Author:

Jungbluth Achim A.,King Roy,Fisher David E.,Iversen Kristin,Coplan Keren,Kolb Denise,Williamson Barbara,Chen Yao-Tseng,Stockert Elisabeth,Old Lloyd J.,Busam Klaus J.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Medical Laboratory Technology,Anatomy

Reference46 articles.

1. Epithelioid Angiomyolipoma of the Kidney

2. Renal Angiomyolipoma

3. Melanocyte-marker-HMB-45 is regularly expressed in angiomyolipoma of the kidney

4. Renal angiomyolipomas and HMB-45 reactivity

5. Lymphangiomyomatosis and angiomyolipoma: closely related entities characterized by hamartomatous proliferation of HMB-45-positive smooth muscle

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In Situ Protein Expression Analysis of Melanocyte Differentiation Antigen TRP1 (Tyrosinase-Related Protein-1);The American Journal of Dermatopathology;2024-06-28

2. High prevalence of MiTF staining in undifferentiated pleomorphic sarcoma: caution in the use of melanocytic markers in sarcoma;Histopathology;2017-02-01

3. Microphthalmia transcription factor immunohistochemistry for FNA biopsy of ocular malignant melanoma;Cancer Cytopathology;2015-02-24

4. Value of melanocytic-associated immunohistochemical markers in the diagnosis of malignant melanoma: a review and update;Human Pathology;2014-02

5. Biology and Clinical Relevance of the Micropthalmia Family of Transcription Factors in Human Cancer;Journal of Clinical Oncology;2011-09-01